How the DMD Hub helps Industry

The DMD Hub helps upskill sites by providing training, mentoring and resources to help ensure that the requirements for DMD clinical trials set by industry are met.

The DMD Hub works collaboratively with industry partners, to act as a one-stop-shop, providing advice and support as they set-up and run DMD clinical trials. 

We have a flexible approach, evolving and developing additional tools as required, and to provide tailoured support as detailed below:

If you would like any more information about these areas, or about other aspects around setting up DMD trials, please contact DMD Hub Manager, Emma Heslop

Collaborators 

The DMD Hub is always actively collaborating with industry partners interested in running clinical trials in the UK. We have also worked closely with academic principal investigators (PIs) to develop academic-led clinical trials. 

We are currently speaking with:

Below you can find the companies we have supported since 2016, and who we are also working with currently:

Pfizer Inc

DMD C3391003 (Phase 3)

Domagrozumab (Phase 2)

Reveragen

 Vamorolone / VBP15 (Phase 2a/2b)

Vamorolone (Phase 2 Extension)

Duchenne UK / Academic / EU collaboration

Tamoxifen (Phase 2)  

Wave Life Sciences

 Next Generation AON Exon Skipping (Phase 1)

DYSTANCE 51 (Phase 2)

 Catabasis Pharmaceuticals

PolarisDMD (Phase 3)

GalaxyDMD (OLE)

Santhera Pharmaceuticals

SIDEROS (Phase 3)

SIDEROS (OLE)

Italfarmaco

Givinostat (EPIDYS) (Phase 3)

Givinostat (OLE)

 Sarepta Therapeutics

MOMENTUM (Phase 2)

Essence (Phase 3)

Casimersen/Golodirsen (OLE)

Sarepta 53 (Phase 1/2)

PTC Therapeutics

Ataluren (Phase 3)

Ataluren (OLE)

Stride Patient Registry

Roche RO7239361 (Phase 2/3)
Summit Ezutromid (Phase 2)

 

Academic Collaboration

Testosterone for DMD (Observational)

FOR-DMD (Observational)

 

We have placed cookies on your computer to help make this website better. For more information please click here

By continuing to use this site or closing this panel, we'll assume you're OK to continue. You can view our full privacy policy here